ZA925306B - 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents - Google Patents
2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agentsInfo
- Publication number
- ZA925306B ZA925306B ZA925306A ZA925306A ZA925306B ZA 925306 B ZA925306 B ZA 925306B ZA 925306 A ZA925306 A ZA 925306A ZA 925306 A ZA925306 A ZA 925306A ZA 925306 B ZA925306 B ZA 925306B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxypiperidino
- alkanol derivatives
- antiischemic agents
- antiischemic
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73157791A | 1991-07-17 | 1991-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA925306B true ZA925306B (en) | 1994-01-17 |
Family
ID=24940103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA925306A ZA925306B (en) | 1991-07-17 | 1992-07-16 | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0594729A1 (cs) |
JP (1) | JP2571904B2 (cs) |
KR (1) | KR0165003B1 (cs) |
CN (1) | CN1043759C (cs) |
AU (1) | AU655840B2 (cs) |
BR (1) | BR9206272A (cs) |
CA (1) | CA2113568A1 (cs) |
CZ (1) | CZ284133B6 (cs) |
EG (1) | EG20048A (cs) |
FI (2) | FI981956A7 (cs) |
HU (1) | HUT70528A (cs) |
IE (1) | IE922311A1 (cs) |
IL (1) | IL102473A (cs) |
MX (1) | MX9204190A (cs) |
NO (1) | NO180445C (cs) |
NZ (1) | NZ243580A (cs) |
PL (1) | PL169884B1 (cs) |
PT (1) | PT100689B (cs) |
RU (1) | RU2065859C1 (cs) |
TW (1) | TW201732B (cs) |
WO (1) | WO1993002052A1 (cs) |
ZA (1) | ZA925306B (cs) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5436255A (en) * | 1992-07-23 | 1995-07-25 | Pfizer Inc. | Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
JP2695292B2 (ja) * | 1992-10-30 | 1997-12-24 | フアイザー・インコーポレイテツド | 神経保護性3,4−ジヒドロ−(1h)−キノロン化合物 |
US5498610A (en) * | 1992-11-06 | 1996-03-12 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
US6978166B2 (en) | 1994-10-07 | 2005-12-20 | Saint Louis University | System for use in displaying images of a body part |
ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
ZA9610736B (en) | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
CA2220649C (en) * | 1996-12-03 | 2007-02-13 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
EP1182193A4 (en) * | 1999-04-09 | 2002-09-11 | Mochida Pharm Co Ltd | REMEDIES FOR NEUROGENIC PAIN |
TWI254043B (en) * | 1999-06-08 | 2006-05-01 | Hoffmann La Roche | Ethanesulfonyl-piperidine derivatives having good affinity to N-methyl-D-aspartate (NMDA) receptor |
US6291499B1 (en) | 1999-10-29 | 2001-09-18 | Merck & Co., Inc. | 2-cyclohexyl benzimidazole NMDA/NR2B antagonists |
US6495561B2 (en) | 1999-10-29 | 2002-12-17 | Merck & Co., Inc. | 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists |
US6380205B1 (en) | 1999-10-29 | 2002-04-30 | Merck & Co., Inc. | 2-cyclohexyl quinazoline NMDA/NR2B antagonists |
US6369076B1 (en) | 1999-10-29 | 2002-04-09 | Merck & Co. Inc. | 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists |
US6476041B1 (en) | 1999-10-29 | 2002-11-05 | Merck & Co., Inc. | 1,4 substituted piperidinyl NMDA/NR2B antagonists |
JP2003512422A (ja) | 1999-10-29 | 2003-04-02 | メルク シャープ エンド ドーム リミテッド | ベンズイミダゾールnmda/nr2bアンタゴニストを使用する疼痛の治療方法 |
US6432976B1 (en) | 1999-10-29 | 2002-08-13 | Merck & Co., Inc. | 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists |
US6316474B1 (en) | 1999-10-29 | 2001-11-13 | Merck & Co., Inc. | 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists |
US6489477B1 (en) | 1999-10-29 | 2002-12-03 | Merck & Co., Inc. | 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists |
CZ20032258A3 (cs) | 2001-02-23 | 2004-01-14 | Merck & Co., Inc. | N-substituované nearylové heterocyklické sloučeniny |
EP1390034A4 (en) | 2001-04-03 | 2005-07-13 | Merck & Co Inc | NMDA / NR2B NONARYL-HETEROCYCLO AMIDYL N-SUBSTITUTE ANTAGONISTS |
EP1568688B1 (en) | 2002-11-25 | 2011-08-31 | Mochida Pharmaceutical Co., Ltd. | Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
WO2005035523A1 (en) * | 2003-10-08 | 2005-04-21 | Pfizer Japan Inc. | Fused lactam compounds |
TWI409289B (zh) | 2010-09-02 | 2013-09-21 | Taiwan Union Technology Corp | 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途 |
MX2022016183A (es) * | 2020-06-23 | 2023-02-13 | Biohaven Therapeutics Ltd | Formulaciones topicas de (1s)-1-fenil-2-piridin-2-iletanamina. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
FR2546166B1 (fr) * | 1983-05-19 | 1985-10-25 | Synthelabo | Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique |
FR2640266B2 (fr) * | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
ES2098248T3 (es) * | 1989-05-17 | 1997-05-01 | Pfizer | Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos. |
AU642994B2 (en) * | 1990-05-10 | 1993-11-04 | Pfizer Inc. | Neuroprotective indolone and related derivatives |
-
1992
- 1992-06-19 HU HU9400136A patent/HUT70528A/hu unknown
- 1992-06-19 AU AU23225/92A patent/AU655840B2/en not_active Ceased
- 1992-06-19 EP EP92915510A patent/EP0594729A1/en not_active Ceased
- 1992-06-19 WO PCT/US1992/004973 patent/WO1993002052A1/en not_active Application Discontinuation
- 1992-06-19 JP JP5502784A patent/JP2571904B2/ja not_active Expired - Lifetime
- 1992-06-19 CA CA002113568A patent/CA2113568A1/en not_active Abandoned
- 1992-06-19 RU RU9294012366A patent/RU2065859C1/ru active
- 1992-06-19 FI FI981956A patent/FI981956A7/fi unknown
- 1992-06-19 PL PL92302290A patent/PL169884B1/pl unknown
- 1992-06-19 CZ CS924008A patent/CZ284133B6/cs not_active IP Right Cessation
- 1992-06-19 FI FI940192A patent/FI940192A7/fi unknown
- 1992-06-19 BR BR9206272A patent/BR9206272A/pt not_active Application Discontinuation
- 1992-06-23 TW TW081104921A patent/TW201732B/zh active
- 1992-07-12 IL IL102473A patent/IL102473A/xx not_active IP Right Cessation
- 1992-07-15 PT PT100689A patent/PT100689B/pt not_active IP Right Cessation
- 1992-07-16 IE IE231192A patent/IE922311A1/en not_active Application Discontinuation
- 1992-07-16 EG EG39792A patent/EG20048A/xx active
- 1992-07-16 NZ NZ243580A patent/NZ243580A/en unknown
- 1992-07-16 CN CN92105921A patent/CN1043759C/zh not_active Expired - Fee Related
- 1992-07-16 ZA ZA925306A patent/ZA925306B/xx unknown
- 1992-07-16 MX MX9204190A patent/MX9204190A/es unknown
-
1994
- 1994-01-14 NO NO940144A patent/NO180445C/no not_active IP Right Cessation
- 1994-01-15 KR KR1019940700124A patent/KR0165003B1/ko not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL102473A0 (en) | 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents | |
GR3023621T3 (en) | 3-Hydroxy-4-aryl-5-oxo-pyrazolin derivatives | |
PL307812A1 (en) | Substituted thiazolydinone derivatives | |
EP0586537A4 (en) | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents | |
HU9203994D0 (en) | Imidazo-pyridine derivatives | |
GB9100505D0 (en) | Piperidine derivatives | |
HU9202768D0 (en) | Cyano-phenyl-pyrrole derivatives | |
EP0438690A3 (en) | Substituted pyrazolin derivatives | |
HU9303225D0 (en) | Benzofurane derivatives | |
FI925295L (fi) | Baenksystem foer kompositioner avsedda foer jordbruk | |
HU9202388D0 (en) | Aryl-alkyl-amine derivatives | |
ZA92278B (en) | 3-quinuclidine derivatives | |
EP0520435A3 (en) | Dc-89 derivatives | |
ZA922976B (en) | 4-Aryl-3-heteroarylureidoquinoline derivatives | |
GB9320940D0 (en) | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative agents | |
GB2262739B (en) | Benzofuranylimidazole derivatives | |
GB9102423D0 (en) | Pryimidinyl-and triazinylsalicyl-and-picolinylaldehyde derivatives | |
ZA931516B (en) | Substituted phenylquinazoline derivatives | |
HU9200105D0 (en) | Bipiridyl derivatives | |
EP0578560A3 (en) | Amido-alcohol derivatives as psychotropic agents | |
IE901154L (en) | Thioformamide derivatives | |
GB9106070D0 (en) | Benzodioxanylimidazole derivatives | |
GB9110611D0 (en) | Pyrrolo-pyriding derivatives | |
GB9213972D0 (en) | 3-cycloalkyl-prop-2-enamide derivatives | |
GB9111684D0 (en) | Imidazopiperidine derivatives |